文献速递心脏核医学肿瘤 PET/CT

心血管PET/MR:需要证据,而非炒作

Cardiovascular PET/MR: We need evidence, not hype.
PubMed 文献 · J Nucl Cardiol · 2016-11-29

本文是一篇社论,对心血管混合正电子发射断层成像/磁共振(PET/MR)的现有证据进行批判性评估,指出多数已发表数据仍处于可行性或临床前阶段,强调需证明其相对心脏磁共振(CMR)的附加获益,并面临成本与电离辐射方面的挑战。

要点

  • 混合PET/MR在心血管医学的应用多数数据仍处于可行性或临床前阶段。
  • 需证明PET/MR相对CMR的附加获益,并面对高成本与电离辐射的挑战。
  • 倡导新技术者负有提供附加获益证据的责任。

核心结论

  • PET/MR在心血管领域的临床应用需提供证据而非炒作,多数已发表数据仍处于可行性或临床前阶段。

研究设计与样本

  • 本文为社论,对心血管PET/MR现有证据进行批判性评估。

主要发现

  • 混合PET/MR扫描仪的应用引发关注,但多数已发表数据仍处于可行性或临床前阶段。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recent introduction of hybrid positron emission tomography/magnetic resonance (PET/MR) scanners has created excitement regarding potential applications in cardiovascular medicine. This has led to a number of optimistic assessments of its potential value in the nuclear cardiology literature, although most published data are still at the feasibility or pre-clinical level. Such excitement is understandable and provides "fuel" for generation of the necessary clinical validation studies, which will be required. Given the current scrutiny from payers and government agencies to reduce the costs of cardiac imaging, the responsibility for showing additive benefit lies on the shoulders of those advocating for new, more expensive technologies. In the case of PET/MR, this will be a major challenge, given the high costs of the hybrid procedure and the need for potentially harmful ionizing radiation compared to a cardiac magnetic resonance (CMR)-only approach. The aim of this editorial is to provide a critical appraisal of the current evidence base for clinical use of PET/MR in cardiology.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Farzaneh-Far A, Kwong RY. Cardiovascular PET/MR: We need evidence, not hype. J Nucl Cardiol. 2016. PMID: 27900641. doi:10.1007/s12350-016-0715-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。